🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.41
-1.01 (-1.64%)
At close: Nov 20, 2026, 4:00 PM EST
60.41
0.00 (0.00%)
After-hours: Nov 20, 2026, 4:15 PM EST

BioMarin Pharmaceutical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-19.12348.9426.86167.65141.56-64.08
Depreciation & Amortization
257.5572.1696.43104.39101.97108.04
Other Amortization
7.47.4----
Loss (Gain) From Sale of Assets
---10--108-
Asset Writedown & Restructuring Costs
419.51345.9819.8938.61--
Loss (Gain) From Sale of Investments
-4.8-4.8-8.35-9.233.045.16
Stock-Based Compensation
219.6181.41201.57207.1196.31197.26
Other Operating Activities
113.26170.6162.84-12.71-62.6-7.88
Change in Accounts Receivable
-181.11-228.05-57.91-190.44-82.0365.57
Change in Inventory
-19.75-116.93-63.53-157.06-68.26-35.06
Change in Accounts Payable
-106.0266.14-32.2468.8559.0215.69
Change in Other Net Operating Assets
-9.9-14.81-62.72-57.9-5.119.83
Operating Cash Flow
676.62827.99572.84159.26175.9304.54
Operating Cash Flow Growth
-25.97%44.54%259.69%-9.46%-42.24%256.75%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-118.75-103.04-85.42-96.69-120.96-95.58
Cash Acquisitions
-5,353-285.19----
Sale (Purchase) of Intangibles
-0.63-7.94-1.99-10.9292.74-23.65
Investment in Securities
742.13-18.07222.77-3.638.19-246.09
Other Investing Activities
4.38-1.14---0.99
Investing Cash Flow
-4,726-414.24136.49-111.24-20.03-366.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
---494.99---3.04
Net Debt Issued (Repaid)
3,635--494.99---3.04
Issuance of Common Stock
13.414.4649.2869.3569.3349.19
Repurchase of Common Stock
-46.03-55.97-77.56-76.32-54.28-45.81
Other Financing Activities
-66.49-0.89-3.18-11.76-33.7-0.4
Financing Cash Flow
3,536-42.39-526.45-18.73-18.65-0.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.9-2.524.831.310.03-0.06
Net Cash Flow
-514.1368.84187.7230.6137.26-61.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
557.86724.96487.4262.5754.94208.96
Free Cash Flow Growth
-32.96%48.73%679.02%13.88%-73.71%-
Free Cash Flow Margin
15.26%22.50%17.08%2.59%2.62%11.32%
Free Cash Flow Per Share
2.893.672.480.330.291.14
Levered Free Cash Flow
-16.04402.66212.05-17.35137.32201.61
Unlevered Free Cash Flow
69.37409.47219.97-6.52147.3211.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
69.727.2510.3610.310.2810.4
Cash Income Tax Paid
100.3896.2157.2773.3154.3718.15
Change in Working Capital
-316.78-293.66-216.4-336.54-96.3866.03
SEC Filings: 10-K · 10-Q